Abstract Library

#2138 Eterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience In Italy

Introduction: The optimal management of duodenal neuroendocrine neoplasms (dNENs) is unclear and endoscopic resection is increasingly performed instead of surgery.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Rossi R

Authors: Massironi S, Campana D, Partelli S, Panzuto F, Rossi R,

Keywords: duodenal neuroendocrine neoplasm, duodenum, gastrinoma, somatostatinoma, diagnosis, therap, guidelines,

#1822 Heterogeneity of Type 1 Gastric Neuroendocrine Neoplasms

Introduction: Type 1 gastric Neuroendocrine Neoplasms (gNENs) are defined when atrophic body gastritis is associated. They are mostly multiple, small, with a low grade histology with low metastatic risk. Data on factors associated with malignant tumor behavior in these patients are scarce.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Rinzivillo M

Authors: Rinzivillo M, Panzuto F, Campana D, Massironi S, Faggiano A,

Keywords: Gastric NEN, Grading ,

#1803 Type 3 Gastric Neuroendocrine Neoplasms: Relationship Between Tumor Size, Ki67 and Clinical Outcome

Introduction: Sporadic type 3 gNENs are usually malignant with high metastatic potential, mostly large, with a high grade histology. However, little is known on the relationship between tumor size, proliferative index Ki67, and clinical outcome

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Panzuto F

Authors: Panzuto F, Campana D, Faggiano A, Massironi S, Rinzivillo M,

Keywords: gastric neuroendocrine tumors, ki67, tumor size,

#1785 Eterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience in Italy

Introduction: Duodenal neuroendocrine neoplasms (dNENs) are heterogeneous tumors, which could have a highly variable prognosis.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Rossi, Roberta Elisa r

Authors: Massironi S, Panzuto F, Rinzivillo M, Rossi R, Delle Fave G,

Keywords: duodenal neuroendocrine neoplasm, duodenum, gastrinoma, somatostatinoma, diagnosis, therapy guidelines,

#1368 Everolimus in Pancreatic Neuroendocrine Carcinomas G3

Introduction: Neuroendocrine Carcinomas (NEC) G3 are heterogeneous diseases with different behaviors, basing on tumor morphology and Ki67 value. Platinum-based chemotherapy is considered the standard treatment in these pts. However, tumors with well-moderately differentiated morphology (NET G3), with Ki67 < 55% may be considered a separate entity in terms of prognosis and therapeutic options

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Panzuto F

Authors: Panzuto F, Rinzivillo M, Spada F, Antonuzzo L, Ibrahim T,

Keywords: Neuroendocrine carcinoma, everolimus,